Data dictionary: Gynecological oncology - DGOA: Difference between revisions

From Beacon
(Created page with "Go back to Dutch Institute for Clinical Auditing Databases (DICA) (The Netherlands) page. This is a summary of the variables available in the database. You can download the complete data dictionary. [https://dica.nl/data-aanvragen/ Click here to learn more]. '''Healthcare Facility Information''' * Health Care Institution * Unique Patient Number '''Patient Demographics''' * Date of Birth * Gender * Date of Death (if applicable) '''Medical History & Comorbidities...")
 
No edit summary
Line 1: Line 1:
{{forresearchers}}
Go back to [[Dutch Institute for Clinical Auditing Databases (DICA) (The Netherlands)]] page.
Go back to [[Dutch Institute for Clinical Auditing Databases (DICA) (The Netherlands)]] page.


This is a summary of the variables available in the database. You can download the complete data dictionary. [https://dica.nl/data-aanvragen/ Click here to learn more].
This is a summary of the variables available in the database. You can download the complete data dictionary. [https://dica.nl/data-aanvragen/ Click here to learn more].


'''Healthcare Facility Information'''
'''Table 1:''' Healthcare Facility Information.
* Health Care Institution
{| class="wikitable"
* Unique Patient Number
! Variables
|-
| Health Care Institution
|-
| Unique Patient Number
|}


'''Table 2:''' Patient Demographics.
{| class="wikitable"
! Variables
|-
| Date of Birth
|-
| Gender
|-
| Date of Death (if applicable)
|}


'''Patient Demographics'''
'''Table 3:''' Medical History & Comorbidities.
* Date of Birth
{| class="wikitable"
* Gender
! Variables
* Date of Death (if applicable)
|-
| Date Comorbidities Were Determined
|-
| Previous Comorbidities
|-
| Myocardial Infarction
|-
| Congestive Heart Failure
|-
| Peripheral Vascular Disease/Aortic Aneurysm
|-
| Cerebrovascular Disease (e.g., Stroke/TIA)
|-
| Dementia
|-
| Chronic Lung Disease
|-
| Connective Tissue Disease (e.g., Rheumatic Diseases)
|-
| Gastrointestinal Ulcer Disease
|-
| Liver Disease
|-
| Diabetes Mellitus
|-
| Paralysis/Hemiplegia
|-
| Kidney Disease
|-
| Malignancy (excluding PCC or BCC of the skin)
|-
| HIV/AIDS
|-
| Thrombosis/Pulmonary Embolism
|-
| Hypertension
|}


'''Table 4:''' Gynecological Information
{| class="wikitable"
! Variables
|-
| Date of First Presentation to Gynecologist
|-
| Menopausal Status
|-
| Pregnancy at Diagnosis
|-
| Fertility Preservation Considered in Treatment?
|}


'''Medical History & Comorbidities'''
'''Table 5:''' Surgical and Treatment Information
* Date Comorbidities Were Determined
{| class="wikitable"
* Previous Comorbidities
! Variables
* Myocardial Infarction
|-
* Congestive Heart Failure
| Date of Surgery
* Peripheral Vascular Disease/Aortic Aneurysm
|-
* Cerebrovascular Disease (e.g., Stroke/TIA)
| Patient Discussed in a Multidisciplinary Team
* Dementia
|-
* Chronic Lung Disease
| Patient Discussed in a Postoperative Multidisciplinary Team
* Connective Tissue Disease (e.g., Rheumatic Diseases)
|-
* Gastrointestinal Ulcer Disease
| Treatment Undertaken or Reason for No Treatment
* Liver Disease
|-
* Diabetes Mellitus
| Type of Tumor for Current Registration
* Paralysis/Hemiplegia
|-
* Kidney Disease
| Participation in a Study
* Malignancy (excluding PCC or BCC of the skin)
|-
* HIV/AIDS
| FIGO (2018) Classification - Overall
* Thrombosis/Pulmonary Embolism
|}
* Hypertension


'''Table 6:''' Pathological Analysis
{| class="wikitable"
! Variables
|-
| Date Material Sent for Pathological Analysis
|-
| PA Laboratory
|-
| PA Number (TJJ-CCCCCC) for Preoperative Diagnosis
|-
| Method of Material Collection for PA
|-
| Histological Type of Tumor
|-
| Largest Tumor Size Outside Pelvis
|-
| Ovarian Removal Status (Unilateral/Bilateral)
|-
| Capsule Status
|-
| Total Number of Lymph Nodes
|-
| Total Number of Positive Lymph Nodes
|}


'''Gynecological Information'''
'''Table 7:''' Complications and Follow-up
* Date of First Presentation to Gynecologist
{| class="wikitable"
* Menopausal Status
! Variables
* Pregnancy at Diagnosis
|-
* Fertility Preservation Considered in Treatment?
| Complications within 30 Days of Resection
|-
| Hospital Readmission within 30 Days of Discharge
|-
| Infections, Injuries, Wound Defects, Bleeding, Thrombosis, Functional Disorders, Systemic, Technical, Lymphedema/Lymphocele?
|-
| Type of Infection, Injury, Wound Defect, Bleeding, Thrombosis, Functional Disorder, Systemic Complication, Technical Complication
|-
| Date of Reintervention
|-
| Reintervention under General Anesthesia?
|}


'''Table 8:''' Chemotherapy and Radiotherapy
{| class="wikitable"
! Variables
|-
| Intent of Chemotherapy
|-
| Start Date of Chemotherapy
|-
| Location of Chemotherapy
|-
| Total Number of Cycles (Neoadjuvant and/or Adjuvant)
|-
| Radiotherapy Date
|-
| Type of Radiotherapy
|-
| Location of Radiotherapy
|}


'''Surgical and Treatment Information'''
'''Table 9:''' Follow-up Information
* Date of Surgery
{| class="wikitable"
* Patient Discussed in a Multidisciplinary Team
! Variables
* Patient Discussed in a Postoperative Multidisciplinary Team
|-
* Treatment Undertaken or Reason for No Treatment
| Date of Most Recent Contact
* Type of Tumor for Current Registration
|-
* Participation in a Study
| Date of Start of Episode for Which This Follow-Up Is Entered
* FIGO (2018) Classification - Overall
|-
| Recurrence?
|-
| Date of First Recurrence
|-
| Treatment for Recurrence (Surgery, Radiotherapy, Chemotherapy, Other Systemic Therapy)
|}


 
'''Table 10:''' COVID-19 Related Information
'''Pathological Analysis'''
{| class="wikitable"
* Date Material Sent for Pathological Analysis
! Variables
* PA Laboratory
|-
* PA Number (TJJ-CCCCCC) for Preoperative Diagnosis
| Suspicion or Test for SARS-CoV-2 Infection Before Admission to 30 Days After Discharge
* Method of Material Collection for PA
|-
* Histological Type of Tumor
| Date of First Suspicion of SARS-CoV-2 Infection
* Largest Tumor Size Outside Pelvis
|-
* Ovarian Removal Status (Unilateral/Bilateral)
| Date of First Specific Test for SARS-CoV-2 Infection
* Capsule Status
|-
* Total Number of Lymph Nodes
| Date of First Positive Lab Test for SARS-CoV-2
* Total Number of Positive Lymph Nodes
|-
 
| ICU Admission and Discharge Dates and Times
 
|-
'''Complications and Follow-up'''
| Final Status Regarding SARS-CoV-2
* Complications within 30 Days of Resection
|}
* Hospital Readmission within 30 Days of Discharge
* Infections, Injuries, Wound Defects, Bleeding, Thrombosis, Functional Disorders, Systemic, Technical, Lymphedema/Lymphocele?
* Type of Infection, Injury, Wound Defect, Bleeding, Thrombosis, Functional Disorder, Systemic Complication, Technical Complication
* Date of Reintervention
* Reintervention under General Anesthesia?
 
 
'''Chemotherapy and Radiotherapy'''
* Intent of Chemotherapy
* Start Date of Chemotherapy
* Location of Chemotherapy
* Total Number of Cycles (Neoadjuvant and/or Adjuvant)
* Radiotherapy Date
* Type of Radiotherapy
* Location of Radiotherapy
 
 
'''Follow-up Information'''
* Date of Most Recent Contact
* Date of Start of Episode for Which This Follow-Up Is Entered
* Recurrence?
* Date of First Recurrence
* Treatment for Recurrence (Surgery, Radiotherapy, Chemotherapy, Other Systemic Therapy)
 
 
'''COVID-19 Related Information'''
* Suspicion or Test for SARS-CoV-2 Infection Before Admission to 30 Days After Discharge
* Date of First Suspicion of SARS-CoV-2 Infection
* Date of First Specific Test for SARS-CoV-2 Infection
* Date of First Positive Lab Test for SARS-CoV-2
* ICU Admission and Discharge Dates and Times
* Final Status Regarding SARS-CoV-2

Revision as of 13:48, 25 May 2024

Go back to Dutch Institute for Clinical Auditing Databases (DICA) (The Netherlands) page.

This is a summary of the variables available in the database. You can download the complete data dictionary. Click here to learn more.

Table 1: Healthcare Facility Information.

Variables
Health Care Institution
Unique Patient Number

Table 2: Patient Demographics.

Variables
Date of Birth
Gender
Date of Death (if applicable)

Table 3: Medical History & Comorbidities.

Variables
Date Comorbidities Were Determined
Previous Comorbidities
Myocardial Infarction
Congestive Heart Failure
Peripheral Vascular Disease/Aortic Aneurysm
Cerebrovascular Disease (e.g., Stroke/TIA)
Dementia
Chronic Lung Disease
Connective Tissue Disease (e.g., Rheumatic Diseases)
Gastrointestinal Ulcer Disease
Liver Disease
Diabetes Mellitus
Paralysis/Hemiplegia
Kidney Disease
Malignancy (excluding PCC or BCC of the skin)
HIV/AIDS
Thrombosis/Pulmonary Embolism
Hypertension

Table 4: Gynecological Information

Variables
Date of First Presentation to Gynecologist
Menopausal Status
Pregnancy at Diagnosis
Fertility Preservation Considered in Treatment?

Table 5: Surgical and Treatment Information

Variables
Date of Surgery
Patient Discussed in a Multidisciplinary Team
Patient Discussed in a Postoperative Multidisciplinary Team
Treatment Undertaken or Reason for No Treatment
Type of Tumor for Current Registration
Participation in a Study
FIGO (2018) Classification - Overall

Table 6: Pathological Analysis

Variables
Date Material Sent for Pathological Analysis
PA Laboratory
PA Number (TJJ-CCCCCC) for Preoperative Diagnosis
Method of Material Collection for PA
Histological Type of Tumor
Largest Tumor Size Outside Pelvis
Ovarian Removal Status (Unilateral/Bilateral)
Capsule Status
Total Number of Lymph Nodes
Total Number of Positive Lymph Nodes

Table 7: Complications and Follow-up

Variables
Complications within 30 Days of Resection
Hospital Readmission within 30 Days of Discharge
Infections, Injuries, Wound Defects, Bleeding, Thrombosis, Functional Disorders, Systemic, Technical, Lymphedema/Lymphocele?
Type of Infection, Injury, Wound Defect, Bleeding, Thrombosis, Functional Disorder, Systemic Complication, Technical Complication
Date of Reintervention
Reintervention under General Anesthesia?

Table 8: Chemotherapy and Radiotherapy

Variables
Intent of Chemotherapy
Start Date of Chemotherapy
Location of Chemotherapy
Total Number of Cycles (Neoadjuvant and/or Adjuvant)
Radiotherapy Date
Type of Radiotherapy
Location of Radiotherapy

Table 9: Follow-up Information

Variables
Date of Most Recent Contact
Date of Start of Episode for Which This Follow-Up Is Entered
Recurrence?
Date of First Recurrence
Treatment for Recurrence (Surgery, Radiotherapy, Chemotherapy, Other Systemic Therapy)

Table 10: COVID-19 Related Information

Variables
Suspicion or Test for SARS-CoV-2 Infection Before Admission to 30 Days After Discharge
Date of First Suspicion of SARS-CoV-2 Infection
Date of First Specific Test for SARS-CoV-2 Infection
Date of First Positive Lab Test for SARS-CoV-2
ICU Admission and Discharge Dates and Times
Final Status Regarding SARS-CoV-2